調査・レポート

A recent report in The American Journal of Clinical Nutrition argues that adding potassium to sodium‑reduction diets may better manage high blood pressure.

AI tools are expanding, and a pharmacy professor highlights pharmacists' role in interpreting digital health data and advising when clinical care is needed.

Boehringer Ingelheim stopped the Phase 1 study of its oral small‑molecule candidate BI 3031185 after a safety event, without revealing details. The trial began in early July in Fukuoka, Japan.

Rhodiola rosea, a high‑altitude plant used traditionally for fatigue and stress, contains the adaptogenic compounds rosavin and salidroside.

Chronic rhinitis affects 10‑40% of people and is divided into allergic and non‑allergic types; treatment typically involves antihistamines, nasal steroids, decongestants, and leukotriene antagonists.

Parkinson’s disease is a neurodegenerative disorder marked by dopamine neuron loss and Lewy bodies, causing motor and non‑motor symptoms; treatment includes dopamine therapy and deep brain stimulation.

Levodopa remains effective for motor symptoms of Parkinson’s disease, but long‑term use brings motor fluctuations and a range of non‑motor issues that heavily impact patients.

Analysis of 2014‑2019 health‑insurance claims shows 38.3% of patients 40+ with Parkinson’s disease were prescribed an average of 2.61 potentially inappropriate meds, 11% of which could worsen symptoms.

Pharmacies find standard pharma pamphlets insufficient and use Claude Design to convert AI‑gathered content into printable A4 brochures.

Research from Columbia University and NY State Psychiatric Institute shows that major depressive disorder blocks the transition of stem cells to new neurons in the hippocampus, linking depression to memory and emotional regulation changes.

Pharmacy reports show medication errors, especially leftover drugs and dosing mistakes, are concentrated among patients aged 65 and older, highlighting the need for targeted medication management.

M2Cloud signed a contract with Moderna to supply its ColdCare cold‑chain IoT service for COVID‑19 vaccine storage and thawing, with on‑site verification completed.